These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36201713)

  • 41. Brain metastases in patients diagnosed with a solid primary cancer during childhood: experience from a single referral cancer center.
    Suki D; Khoury Abdulla R; Ding M; Khatua S; Sawaya R
    J Neurosurg Pediatr; 2014 Oct; 14(4):372-85. PubMed ID: 25127097
    [TBL] [Abstract][Full Text] [Related]  

  • 42. No Prognostic Impact of Staging Brain MRI in Patients with Stage IA Non-Small Cell Lung Cancer.
    Nam JG; Hong H; Choi SH; Park CM; Goo JM; Kim YT; Kim H
    Radiology; 2022 Jun; 303(3):632-643. PubMed ID: 35258373
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastasis.
    Johung KL; Yeh N; Desai NB; Williams TM; Lautenschlaeger T; Arvold ND; Ning MS; Attia A; Lovly CM; Goldberg S; Beal K; Yu JB; Kavanagh BD; Chiang VL; Camidge DR; Contessa JN
    J Clin Oncol; 2016 Jan; 34(2):123-9. PubMed ID: 26438117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predicting the outcome of radiotherapy in brain metastasis by integrating the clinical and MRI-based deep learning features.
    Jalalifar SA; Soliman H; Sahgal A; Sadeghi-Naini A
    Med Phys; 2022 Nov; 49(11):7167-7178. PubMed ID: 35727568
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Who may benefit from prophylactic cranial irradiation amongst stage III non-small cell lung cancer patients?
    Alsan Cetin I; Akgun Z; Atasoy BM; Fulden Yumuk P; Abacioglu U
    J BUON; 2013; 18(2):453-8. PubMed ID: 23818361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Magnetic resonance imaging evaluation of treatment efficacy and prognosis for brain metastases in lung cancer patients after radiotherapy: A preliminary study.
    Liu Y; Liu X; Xu L; Liu L; Sun Y; Li M; Zeng H; Yuan S; Yu J
    Thorac Cancer; 2018 Jul; 9(7):865-873. PubMed ID: 29774659
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
    Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
    Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
    Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
    Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases.
    Furtner J; Berghoff AS; Albtoush OM; Woitek R; Asenbaum U; Prayer D; Widhalm G; Gatterbauer B; Dieckmann K; Birner P; Aretin B; Bartsch R; Zielinski CC; Schöpf V; Preusser M
    Eur Radiol; 2017 Aug; 27(8):3167-3173. PubMed ID: 28050694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Value of screening and follow-up brain MRI scans in patients with metastatic melanoma.
    Eggen AC; Wind TT; Bosma I; Kramer MCA; van Laar PJ; van der Weide HL; Hospers GAP; Jalving M
    Cancer Med; 2021 Dec; 10(23):8395-8404. PubMed ID: 34741440
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer.
    Graesslin O; Abdulkarim BS; Coutant C; Huguet F; Gabos Z; Hsu L; Marpeau O; Uzan S; Pusztai L; Strom EA; Hortobagyi GN; Rouzier R; Ibrahim NK
    J Clin Oncol; 2010 Apr; 28(12):2032-7. PubMed ID: 20308667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical features and prognostic factors of brain metastasis from colorectal cancer].
    Sun Z; Sun Y; Tan L; He J; Li X; She C; Li W
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):63-8. PubMed ID: 26796809
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Computer-aided Detection of Brain Metastases in T1-weighted MRI for Stereotactic Radiosurgery Using Deep Learning Single-Shot Detectors.
    Zhou Z; Sanders JW; Johnson JM; Gule-Monroe MK; Chen MM; Briere TM; Wang Y; Son JB; Pagel MD; Li J; Ma J
    Radiology; 2020 May; 295(2):407-415. PubMed ID: 32181729
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcomes of prophylactic cranial irradiation in patients with small cell lung cancer in the modern era of baseline magnetic resonance imaging of the brain.
    Held MK; Hansen O; Schytte T; Hansen KH; Bahij R; Nielsen M; Nielsen TB; Jeppesen SS
    Acta Oncol; 2022 Feb; 61(2):185-192. PubMed ID: 34583620
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastases.
    Costa DB; Shaw AT; Ou SH; Solomon BJ; Riely GJ; Ahn MJ; Zhou C; Shreeve SM; Selaru P; Polli A; Schnell P; Wilner KD; Wiltshire R; Camidge DR; Crinò L
    J Clin Oncol; 2015 Jun; 33(17):1881-8. PubMed ID: 25624436
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brain metastases from adenocarcinoma of the lung with truly cystic magnetic resonance imaging appearance.
    Essenmacher AC; Watal P; Bathla G; Bruch LA; Moritani T; Capizzano AA
    Clin Imaging; 2018; 52():203-207. PubMed ID: 30125846
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer: comparisons of clinical effectiveness in a randomized trial.
    Yi CA; Lee KS; Lee HY; Kim S; Kwon OJ; Kim H; Choi JY; Kim BT; Hwang HS; Shim YM
    Cancer; 2013 May; 119(10):1784-91. PubMed ID: 23423920
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non-Small Cell Lung Cancer and Rate of Central Nervous System Progression on Crizotinib.
    Patil T; Smith DE; Bunn PA; Aisner DL; Le AT; Hancock M; Purcell WT; Bowles DW; Camidge DR; Doebele RC
    J Thorac Oncol; 2018 Nov; 13(11):1717-1726. PubMed ID: 29981925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Validity of a Recently Proposed Prognostic Grading Index, Brain Metastasis Velocity, for Patients With Brain Metastasis Undergoing Multiple Radiosurgical Procedures.
    Yamamoto M; Aiyama H; Koiso T; Watanabe S; Kawabe T; Sato Y; Higuchi Y; Kasuya H; Barfod BE
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):631-637. PubMed ID: 30395905
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of Low-Dose Computed Tomography Screening for Primary Lung Cancer on Subsequent Risk of Brain Metastasis.
    Su CC; Wu JT; Neal JW; Popat RA; Kurian AW; Backhus LM; Nagpal S; Leung AN; Wakelee HA; Han SS
    J Thorac Oncol; 2021 Sep; 16(9):1479-1489. PubMed ID: 34091050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.